Chemotherapy and radiotherapy in early stage uterine papillary serous and clear-cell carcinoma: A National Cancer Data Base study.

Julian C. Hong, Jonathan Foote, Laura J. Havrilesky, Stéphanie Gaillard, Junzo ChinoJournal of Clinical Oncology 2016 · DOI

Abstract

5590 Background: Adjuvant chemotherapy (CT) and radiotherapy (RT) are often part of management of early stage uterine papillary serous (UPSC) and clear cell carcinoma (UCC), though their benefit remains unclear. This study uses a national cohort to study the benefit and interaction of lymph node dissection (LND), CT and RT in stage I UPSC and UCC. Methods: The National Cancer Data Base (NCDB) was queried for all women with FIGO 2009 stage I UPSC and UCC diagnosed from 1998 to 2012 who underwent at least total hysterectomy. Overall survival (OS) was estimated for combinations of RT and CT by the Kaplan-Meier method stratified by histology and LND. RT included external beam RT, vaginal brachytherapy (VBT) or both. Multivariate Cox proportional hazards models of OS were generated. Results: UPSC: 5432 women with UPSC were identified. UPSC with LND had longer 5-year OS with CT+RT (83% [95% CI 79-87%]) than CT (79% [75-83%]), RT (72% [68-75%]) or surgery alone (71% [69-74%]) (p < 0.001). Without LND, CT+RT (76% [63-88%]) had longer OS than RT (55% [46-66%]), CT (48% [36-60%]) or hysterectomy alone (53% [48-58%]) (p = 0.02). On multivariate analyses for UPSC with and without LND, age, race, Charlson/Deyo comorbidity, depth of invasion and VBT were independently associated with longer OS. CT was independently associated with OS with LND (HR 0.77, p = 0.01) but not without (HR 1.21, p = 0.92). UCC: 2516 women with UCC were identified. UCC with LND had comparable 5-year OS for CT+RT (83% [76-89%]), CT (81% [74-89%]), RT (76% [72-81%]) or surgery alone (78% [74-81%]) (p = 0.21). Without LND, OS was similar for CT+RT (66% [45-88%]), CT (56% [28-84%]), RT (58% [45-72%]) and hysterectomy alone (47% [38-55%]) (p = 0.47). On multivariate analysis for UCC with LND, age, comorbidity and depth of invasion were independently associated with OS. Without LND, only age independently predicted OS. CT was not independently associated with OS with LND (HR 1.12, p = 0.51) or without (HR 1.07, p = 0.84). VBT was also not associated with OS with LND (HR 1.01, p = 0.97) or without (HR 0.42, p = 0.06). Conclusions: VBT was associated with longer OS in stage I UPSC. CT benefit was limited to those with LND. No adjuvant therapy was associated with OS in stage I UCC.
BibTeX
@article{hong2016chemotherapy,
  author = {Julian C. Hong and Jonathan Foote and Laura J. Havrilesky and Stéphanie Gaillard and Junzo Chino},
  title = {{Chemotherapy and radiotherapy in early stage uterine papillary serous and clear-cell carcinoma: A National Cancer Data Base study.}},
  journal = {Journal of Clinical Oncology},
  year = {2016},
  doi = {10.1200/jco.2016.34.15\_suppl.5590},
}

Loading related content...

Figure